Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

1. Maurel, J.
2. Sánchez-Cabús, S.
3. Laquente, B.
4. Gaba, L.
5. Visa, L.
6. Fabregat, J.
7. Povés, I.
8. Roselló, S.
9. Díaz-Beveridge, R.
10. Martín-Richard, M.
11. Rodriguez, J.
12. Sabater, L.
13. Conill, C.
14. Cambray, M.
15. Reig, A.
16. Ayuso, J.R.
17. Valls, C.
18. Ferrández, A.
19. Bombí, J.A.
20. Ginés, A.
21. García-Albéniz, X.
22. Fernández-Cruz, L.